Physician profile
Frank A Liporace
NPI 1689679722
$3,613,051.85
in general payments reported to CMS, 2019-2025
65 companies · $976K in 2025
The $976K reported for 2025 was more than what 99% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246K · 2020: $214K · 2021: $156K · 2022: $555K · 2023: $841K · 2024: $626K · 2025: $976K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.2M · Consulting Fee: $224K · Travel and Lodging: $22K · Food and Beverage: $12K · Education: $8,535 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,175,366.40 |
| Consulting Fee | $224,268.70 |
| Travel and Lodging | $21,549.32 |
| Food and Beverage | $12,413.45 |
| Education | $8,534.58 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $324.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $2,039,167.47 | 2022-2025 | Na |
| Zimmer Biomet Holdings, INC. | $1,240,654.05 | 2019-2025 | Affixus, A.L.P.S., Dvr Anatomic Kickstand |
| Stryker Corporation | $71,371.28 | 2019-2025 | Ortholoc 3di, Triathlon, T2 Alpha |
| Medical Device Business Services, INC. | $67,501.54 | 2019-2025 | Na, Va-Lcp, Tfn-Advance |
| Royal Biologics, INC. | $61,026.56 | 2019-2025 | |
| Smith+Nephew, INC. | $48,903.84 | 2019-2025 | Legion Revision, Evos, Pico 14 |
| Conventus Orthopaedics, INC. | $18,000.00 | 2019-2020 | |
| Synthes USA Products LLC | $14,703.50 | 2019-2024 | Va-Lcp, Na |
| Biocomposites INC | $14,269.47 | 2019-2025 | Stimulan |
| US Implant Solutions, LLC | $9,080.55 | 2024-2025 | |
| Wright Medical Technology, INC. | $5,221.60 | 2019-2020 | |
| Depuy Synthes Sales INC. | $5,168.87 | 2019-2025 | Na, Va-Lcp, Attune |
| Acera Surgical, INC. | $3,162.41 | 2023-2024 | Restrata Wound Matrix |
| Flower Orthopedics Coporation | $2,506.39 | 2020-2021 | |
| Synthes Gmbh | $1,940.00 | 2021-2023 |
Show all 65 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $1,784.04 | 2019-2025 | Distal Femur Plate System, Providence, Proven Gen-Flex Ps Knee System |
| Kerecis Limited | $1,420.06 | 2021-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Baxter Healthcare | $715.10 | 2019-2021 | |
| Nuvasive Specialized Orthopedics, INC. | $489.72 | 2019-2023 | Precice Intramedullary Limb Lengthening System |
| Sanara Medtech INC. | $474.82 | 2024-2025 | Celleraterx |
| Si-Bone, INC. | $465.04 | 2019-2021 | |
| Organogenesis INC. | $428.93 | 2020-2024 | |
| Ethicon US, LLC | $386.72 | 2020-2025 | Vistaseal, Surgicel Nu-Knit, Stratafix |
| Heron Therapeutics, INC. | $300.18 | 2021-2024 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $272.64 | 2020-2022 | |
| Heraeus Medical, LLC. | $237.95 | 2020-2025 | |
| Acumed LLC | $188.87 | 2024 | Inframe Implant, Nanophix Implant, Innate Implant |
| Next Science LLC | $177.18 | 2022-2023 | Xperience, Blastx, Surgx |
| Axogen | $167.76 | 2019-2023 | Avance Nerve Graft |
| Medtronic USA, INC. | $156.78 | 2020 | |
| Stability Biologics, LLC | $155.89 | 2019-2020 | |
| Curvafix, INC. | $149.70 | 2023 | Curvafix Im Implant |
| Trimed, INC. | $145.75 | 2023 | |
| Carbofix Orthopedics INC | $138.68 | 2023 | |
| Pfizer INC. | $134.51 | 2019-2021 | |
| Davol INC. | $132.73 | 2020-2024 | Channel Drain |
| Fusion Orthopedics USA, LLC | $128.10 | 2025 | |
| Kinamed, INC. | $122.75 | 2024 | |
| Integra Lifesciences Corporation | $121.85 | 2019 | |
| Kci USA, INC. | $120.87 | 2020-2021 | |
| Conformis, INC. | $116.79 | 2019 | |
| Medshape, INC. | $116.40 | 2023-2024 | Dynanail, Dynanail Mini, Dynanail Helix, Washer, 15 Mm |
| Onkos Surgical, INC. | $114.73 | 2024 | Eleos Limb Salvage System |
| Sanofi-Aventis U.S. LLC | $111.23 | 2019-2022 | |
| Avanos Medical | $88.47 | 2020-2021 | |
| Bioventus LLC | $82.22 | 2022-2025 | Durolane, Durolane |
| Amdt Holdings, INC. | $79.22 | 2022 | |
| Pacira Therapeutics, INC. | $75.72 | 2019-2020 | |
| Seapearl East, INC | $72.37 | 2025 | |
| Dynasplint Systems INC. | $66.22 | 2019 | |
| Allergan, INC. | $54.60 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $47.26 | 2024-2025 | |
| Paragon 28, INC. | $41.74 | 2020-2022 | |
| Nuvasive, INC. | $37.03 | 2022 | |
| Bonalive INC | $35.34 | 2025 | |
| Medtronic, INC. | $30.62 | 2021-2023 | Aquamantys(Tm) |
| Ermi LLC | $26.96 | 2020 | |
| Conmed Corporation | $26.41 | 2024 | Airseal |
| Baudax Bio INC. | $25.00 | 2020 | |
| Supernus Pharmaceuticals, INC. | $22.05 | 2023 | Qelbree |
| Ferring Pharmaceuticals INC. | $20.98 | 2024 | Euflexxa |
| Fidia Pharma USA INC. | $17.50 | 2019 | |
| Synergy Orthopedics, LLC | $17.32 | 2023 | |
| Astrazeneca Pharmaceuticals Lp | $17.00 | 2023 | Andexxa |
| Daiichi Sankyo INC. | $14.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2.32 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Liporace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.